 Disease Progression
"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 | | 1996 | 0 | 5 | 5 | | 1997 | 0 | 5 | 5 | | 1998 | 0 | 5 | 5 | | 1999 | 0 | 6 | 6 | | 2000 | 0 | 10 | 10 | | 2001 | 0 | 6 | 6 | | 2002 | 0 | 14 | 14 | | 2003 | 0 | 25 | 25 | | 2004 | 0 | 21 | 21 | | 2005 | 1 | 26 | 27 | | 2006 | 0 | 20 | 20 | | 2007 | 1 | 25 | 26 | | 2008 | 0 | 23 | 23 | | 2009 | 0 | 29 | 29 | | 2010 | 2 | 27 | 29 | | 2011 | 2 | 23 | 25 | | 2012 | 2 | 22 | 24 | | 2013 | 2 | 21 | 23 | | 2014 | 3 | 25 | 28 | | 2015 | 4 | 21 | 25 | | 2016 | 5 | 17 | 22 | | 2017 | 4 | 27 | 31 | | 2018 | 2 | 17 | 19 | | 2019 | 1 | 23 | 24 | | 2020 | 3 | 29 | 32 | | 2021 | 2 | 12 | 14 | | 2022 | 1 | 12 | 13 | | 2023 | 0 | 7 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
Batra A, Nath A, Koralnik IJ. Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023 10 17; 330(15):1491-1492.
-
Wong AC, Devason AS, Umana IC, Cox TO, Dohnalov? L, Litichevskiy L, Perla J, Lundgren P, Etwebi Z, Izzo LT, Kim J, Tetlak M, Descamps HC, Park SL, Wisser S, McKnight AD, Pardy RD, Kim J, Blank N, Patel S, Thum K, Mason S, Beltra JC, Michieletto MF, Ngiow SF, Miller BM, Liou MJ, Madhu B, Dmitrieva-Posocco O, Huber AS, Hewins P, Petucci C, Chu CP, Baraniecki-Zwil G, Giron LB, Baxter AE, Greenplate AR, Kearns C, Montone K, Litzky LA, Feldman M, Henao-Mejia J, Striepen B, Ramage H, Jurado KA, Wellen KE, O'Doherty U, Abdel-Mohsen M, Landay AL, Keshavarzian A, Henrich TJ, Deeks SG, Peluso MJ, Meyer NJ, Wherry EJ, Abramoff BA, Cherry S, Thaiss CA, Levy M. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023 10 26; 186(22):4851-4867.e20.
-
Frontera JA, Guekht A, Allegri RF, Ashraf M, Baykan B, Crivelli L, Easton A, Garcia-Azorin D, Helbok R, Joshi J, Koehn J, Koralnik I, Netravathi M, Michael B, Nilo A, ?zge A, Padda K, Pellitteri G, Prasad K, Romozzi M, Saylor D, Seed A, Thakur K, Uluduz D, Vogrig A, Welte TM, Westenberg E, Zhuravlev D, Zinchuk M, Winkler AS. Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition. J Neurol Sci. 2023 Nov 15; 454:120827.
-
Hanson BA, Visvabharathy L, Orban ZS, Jimenez M, Batra A, Liotta EM, DeLisle RK, Klausner JD, Cohen P, Padhye AS, Tachas G, Koralnik IJ. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection. Brain Behav Immun. 2023 Nov; 114:462-474.
-
Beghi E, Ivashynka A, Logroscino G, de Oliveira FF, Fleisher JE, Dumitrascu OM, Patel R, Savica R, Kim YJ. Pitfalls and biases in neuroepidemiological studies of COVID-19 and the nervous system: a critical appraisal of the current evidence and future directions. J Neurol. 2023 Nov; 270(11):5162-5170.
-
Apetrei C, Gaufin T, Brocca-Cofano E, Sivanandham R, Sette P, He T, Sivanandham S, Martinez Sosa N, Martin KJ, Raehtz KD, Kleinman AJ, Valentine A, Krampe N, Gautam R, Lackner AA, Landay AL, Ribeiro RM, Pandrea I. T cell activation is insufficient to drive SIV disease progression. JCI Insight. 2023 07 24; 8(14).
-
Aggarwal NT, Mielke MM. Sex Differences in Alzheimer's Disease. Neurol Clin. 2023 05; 41(2):343-358.
-
Jedel S, Beck T, Swanson G, Hood MM, Voigt RM, Gorenz A, Jakate S, Raeisi S, Hobfoll S, Keshavarzian A. Mindfulness Intervention Decreases Frequency and Severity of Flares in Inactive Ulcerative Colitis Patients: Results of a Phase II, Randomized, Placebo-Controlled Trial. Inflamm Bowel Dis. 2022 12 01; 28(12):1872-1892.
-
Wisk LE, Gottlieb MA, Spatz ES, Yu H, Wang RC, Slovis BH, Saydah S, Plumb ID, O'Laughlin KN, Montoy JCC, McDonald SA, Lin Z, Lin JS, Koo K, Idris AH, Huebinger RM, Hill MJ, Gentile NL, Chang AM, Anderson J, Hota B, Venkatesh AK, Weinstein RA, Elmore JG, Nichol G. Association of Initial SARS-CoV-2 Test Positivity With Patient-Reported Well-being 3 Months After a Symptomatic Illness. JAMA Netw Open. 2022 12 01; 5(12):e2244486.
-
Beck JS, Madaj Z, Cheema CT, Kara B, Bennett DA, Schneider JA, Gordon MN, Ginsberg SD, Mufson EJ, Counts SE. Co-expression network analysis of frontal cortex during the progression of Alzheimer's disease. Cereb Cortex. 2022 11 09; 32(22):5108-5120.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|